Title:PDE-5 Inhibitors for BPH-Associated LUTS
Volume: 16
Issue: 11
Author(s): Philip Brousil, Majid Shabbir, E. Zacharakis and Arun Sahai
Affiliation:
Keywords:
Benign prostatic hyperplasia, LUTS, PDE5 inhibitors, erectile dysfunction.
Abstract: Lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS)
are a highly prevalent problem, and with considerable burden to quality of life. Evidence has emerged
that a strong correlation exists in men suffering both BPH-LUTS and erectile dysfunction (ED). Phosphodiesterase
type 5 inhibitors (PDE5i) have been shown to be highly effective in treating ED and
more recently there is evidence that men with LUTS also benefit. In this review article we discuss the
common pathogenic pathways of ED and LUTS, the scientific basis of PDE5i use, the efficacy of
PDE5i in LUTS either as monotherapy or in combination with other established medications used in
LUTS.